List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 39 studies with search of: VATALANIB
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Trial of PTK787/ZK 222584 Plus Paclitaxel
Condition: Metastatic Non-hematologic Malignancies
Interventions: Drug: PTK787/ZK 222584;   Drug: paclitaxel
2 Completed PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib
Condition: Sarcoma
Intervention: Drug: PTK787/ZK222584
3 Recruiting Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors
Condition: Metastatic Neuroendocrine Tumors
Intervention: Drug: vatalanib
4 Completed PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma
Condition: Neoplasm
Intervention: Drug: PTK787/ZK222584
5 Completed Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: PTK787/ZK 222584
6 Active, not recruiting Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vatalanib;   Drug: warfarin
7 Completed PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies
Conditions: Refractory Malignancy;   Advanced Malignancies
Intervention: Drug: PTK787/ZK222584 and Bevacizumab
8 Terminated PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma
Condition: Lymphoma, Large-Cell, Diffuse
Intervention: Drug: PTK787/ZK 222584
9 Completed Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
Conditions: Colorectal Neoplasms;   Colonic Neoplasms;   Rectal Neoplasms
Intervention: Drug: Vatalanib
10 Completed Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
Conditions: Colorectal Neoplasms;   Colonic Neoplasms;   Rectal Neoplasms
Intervention: Drug: Vatalanib
11 Active, not recruiting Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
Conditions: Brain and Central Nervous System Tumors;   Sarcoma
Intervention: Drug: vatalanib
12 Active, not recruiting Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Conditions: Gastrointestinal Carcinoid Tumor;   Head and Neck Cancer;   Islet Cell Tumor;   Kidney Cancer;   Lung Cancer;   Malignant Paraganglioma;   Melanoma (Skin);   Neuroendocrine Carcinoma of the Skin;   Pheochromocytoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: everolimus;   Drug: vatalanib;   Genetic: protein expression analysis;   Other: high performance liquid chromatography;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Other: pharmacological study;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: ultrasound imaging
13 Completed Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer
Conditions: Tumors;   Neoplasm Metastasis
Intervention: Drug: PTK787/ZK 222584 (vatalanib)
14 Active, not recruiting The Safety and Efficacy of CPTK787/ZK222584 in Patients With Metastatic Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Drug: PTK787/ZK222584 - Experimental
15 Completed Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: hydroxyurea;   Drug: imatinib mesylate;   Drug: vatalanib
16 Active, not recruiting Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors
Conditions: Kidney Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: everolimus;   Drug: vatalanib
17 Active, not recruiting Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Drug: vatalanib;   Procedure: adjuvant therapy;   Radiation: radiation therapy
18 Suspended Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer
Condition: Non-Small Cell Lung Cancer and Pleural Mesothelioma
Intervention: Drug: PTK787 and Pemetrexed with or without Cisplatin
19 Recruiting PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
Condition: Glioblastoma
Interventions: Drug: PTK787/ZK 222584;   Drug: Temozolomide;   Procedure: Radiation Therapy
20 Completed Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584
Conditions: Von Hippel-Lindau Disease;   CNS Hemangioblastoma;   Retinal Hemangioblastoma
Intervention: Drug: PTK787/ZK 222584

Previous Page Studies Shown (1-20) Next Page (21-39)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services